TARS — Tarsus Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$71.03

YTD price return

-13.25%

YTD total return

-13.25%

Next earnings

Nov 3, 2026

Market cap

3.1B2020-12 847.4M2026-10 3.1B+267.8% over the window

Enterprise value

2.8B

Shares outstanding

43.9M2019-12 2.6M2026-06 43.9M+1558.1% over the window

52W low

$53.89

52W high

$91.53

From 52W high

-22.40%

From 52W low

+31.81%

52W range

46%

Volume

Rel volume

0.97×

30D volume

882K

30D $ vol

65.6M

Fundamentals

Sales (ttm)

606.3M2020-12 02026-06 606.3M

Sales/share

$13.822020-12 $0.002026-06 $13.82

EPS (ttm)

-$1.082020-03 -$1.842026-06 -$1.08-41.2% over the window

FCF (ttm)

56M2019-12 -3.8M2026-06 56M-1555.4% over the window

FCF/share

$1.282019-12 -$1.452026-06 $1.28-187.8% over the window

Book value/share

$7.902019-06 -$1.482026-06 $7.90-633.5% over the window

Net margin

-7.67%2021-03 -43.3%2026-06 -7.7%-82.3% over the window

ROE

-13.40%2020-12 -16.2%2026-06 -13.4%-17.0% over the window

ROA

-7.60%2019-12 -8.0%2026-06 -7.6%-5.0% over the window

Debt / equity

0.21×2021-12 0.002026-06 0.21

Current ratio

3.202019-12 70.852026-06 3.20-95.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+105.27%2025-06-30 → 2026-06-30295.5M → 606.3M (+105.2% total)+264.59%2023-06-30 → 2026-06-3012.5M → 606.3M (+4750.6% total)+61.36%2021-06-30 → 2026-06-3055.4M → 606.3M (+993.5% total)n/a

Shares

+3.96%2025-06-30 → 2026-06-3042.2M → 43.9M (+4.0% total)+10.39%2023-06-30 → 2026-06-3032.6M → 43.9M (+34.5% total)+16.36%2021-06-30 → 2026-06-3020.6M → 43.9M (+113.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+97.46%2025-06-30 → 2026-06-30$7.00 → $13.82 (+97.4% total)+230.26%2023-06-30 → 2026-06-30$0.38 → $13.82 (+3505.3% total)+38.67%2021-06-30 → 2026-06-30$2.70 → $13.82 (+412.7% total)n/a

Book value/share

+0.28%2025-06-30 → 2026-06-30$7.88 → $7.90 (+0.3% total)+20.38%2023-06-30 → 2026-06-30$4.53 → $7.90 (+74.4% total)-3.32%2021-06-30 → 2026-06-30$9.36 → $7.90 (-15.5% total)n/a

Price

-0.22%2025-10-20 → 2026-10-20$71.19 → $71.03 (-0.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+75.61%2023-10-20 → 2026-10-20$13.11 → $71.03 (+441.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+20.11%2021-10-20 → 2026-10-20$28.42 → $71.03 (+149.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-0.22%2025-10-20 → 2026-10-20$71.19 → $71.03 (-0.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+75.61%2023-10-20 → 2026-10-20$13.11 → $71.03 (+441.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+20.11%2021-10-20 → 2026-10-20$28.42 → $71.03 (+149.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-65.6×2020-12 -31.612026-10 -67.07+112.2% over the window

Fwd P/E

-139.0×

P/S (ttm)Market cap ÷ TTM revenue.

5.1×2021-03 19.792026-10 5.14-74.0% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

9.0×2020-12 5.112026-10 8.99+76.1% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

55.7×2020-12 -39.242026-10 55.66-241.8% over the window

EV/Sales (ttm)

4.5×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

1.80%2020-09 -1.5%2026-06 2.0%-237.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 43.9M ÷ 42.2M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-3.96%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-3.96%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-3.96%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($134.8M) ÷ today's market cap ($3.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

4.32%2020-09 0.0%2026-06 4.9%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $134.8M + TTM dividends $0) ÷ today's market cap ($3.1B). Same caveat as the cash buyback yield.

4.32%2020-09 0.0%2026-06 4.9%

Vs own 10Y history

P/S

6th

P/B

92nd